Abstract
Objective
To investigate the prevalence of restless legs syndrome (RLS) in maintenance hemodialysis (MHD) patients and its possible influencing factors.
Methods
MHD patients were consecutively enrolled from five hemodialysis centers in Hefei. Clinical, demographics, and laboratory data were recorded from December 2013 to March 2014. RLS diagnosis scale, Zung Self-Rating Depression Scale (SDS), Zung Self-Rating Anxiety Scale (SAS), Pittsburgh Sleep Quality Index (PSQI), and kidney disease and quality of life (KDQOLTM-36) were used for analysis.
Results
A total of 269 MHD patients (81 women, 188 men) were enrolled, among which 39 patients were diagnosed as RLS. The median duration of dialysis therapy was 33 months and the prevalence of RLS was 14.5%. Compared with RLS-negative patients, RLS-positive patients had lower hemoglobin level (98.67 ± 13.50 vs 106.34 ± 17.75, P = 0.011) and higher alkaline phosphatase concentration [131.0 (98.0, 226.0) vs 94.0 (69.8, 157.5), P = 0.001]. The multivariate logistic regression showed that high hemoglobin level (OR 0.975, 95% CI 0.956–0.995, P = 0.015) was a protective factor for RLS, while high alkaline phosphatase (OR 1.003, 95% CI 1.001–1.005, P = 0.018) was an independent risk factor for RLS. RLS patients had significantly higher PSQI scores (P < 0.001), reduced subjective sleep quality (P < 0.001), increased sleep latency (P < 0.007), shorter sleep duration (P < 0.001), lower sleep efficiency (P = 0.001), higher sleep disturbances (P < 0.001), and increased daytime dysfunction (P = 0.019).
Conclusion
Our findings demonstrated that the prevalence of RLS was 14.5% in Hefei. High hemoglobin level was a protective factor for RLS, and high alkaline phosphatase was an independent risk factor. RLS affects many aspects of quality of life and sleep quality, which may contribute to the presence of depression and anxiety.
Similar content being viewed by others
References
Ekbom K, Ulfberg J (2009) Restless legs syndrome. J Intern Med 266(5):419–431
Molnar MZ, Novak M, Ambrus C, Szeifert L, Kovacs A, Pap J, Remport A, Mucsi I (2005) Restless legs syndrome in patients after renal transplantation. Am J Kidney Dis 45(2):388–396
Mucsi I, Molnar MZ, Ambrus C, Szeifert L, Kovacs AZ, Zoller R, Barotfi S, Remport A, Novak M (2005) Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol Dial Transplant 20(3):571–577
Garnock-Jones KP (2016) Rotigotine transdermal patch: a review in restless legs syndrome. Drugs 76(10):1031–1040
Murtagh FE, Addington-Hall J, Higginson IJ (2007) The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis 14(1):82–99
Allen RP (2007) Controversies and challenges in defining the etiology and pathophysiology of restless legs syndrome. Am J Med 120(1 Suppl 1):S13–S21
Pellecchia MT, Vitale C, Sabatini M, Longo K, Amboni M, Bonavita V, Barone P (2004) Ropinirole as a treatment of restless legs syndrome in patients on chronic hemodialysis: an open randomized crossover trial versus levodopa sustained release. Clin Neuropharmacol 27(4):178–181
Szentkiralyi A, Molnar MZ, Czira ME, Deak G, Lindner AV, Szeifert L, Torzsa P, Vamos EP, Zoller R, Mucsi I, Novak M (2009) Association between restless legs syndrome and depression in patients with chronic kidney disease. J Psychosom Res 67(2):173–180
Rafie S, Jafari M, Azizi M, Bahadoram M, Jafari S (2016) Restless legs syndrome in hemodialysis patients. Saudi J Kidney Dis Transplant 27(2):326–330
Chen WC, Lim PS, Wu WC, Chiu HC, Chen CH, Kuo HY, Tsai TW, Chien PI, Su YJ, Su YL, Hung SH, Woods HF (2006) Sleep behavior disorders in a large cohort of chinese (Taiwanese) patients maintained by long-term hemodialysis. Am J Kidney Dis 48(2):277–284
Li Y, Wang W, Winkelman JW, Malhotra A, Ma J, Gao X (2013) Prospective study of restless legs syndrome and mortality among men. Neurology 81(1):52–59
Li Y, Walters AS, Chiuve SE, Rimm EB, Winkelman JW, Gao X (2012) Prospective study of restless legs syndrome and coronary heart disease among women. Circulation 126(14):1689–1694
Szentkiralyi A, Winter AC, Schurks M, Volzke H, Hoffmann W, Buring JE, Gaziano JM, Kurth T, Berger K (2012) Restless legs syndrome and all-cause mortality in four prospective cohort studies. BMJ Open 2(6):e001652
La Manna G, Pizza F, Persici E, Baraldi O, Comai G, Cappuccilli ML, Centofanti F, Carretta E, Plazzi G, Coli L, Montagna P, Stefoni S (2011) Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. Nephrol Dial Transpl 26(6):1976–1983
Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. Sleep Med 4(2):101–119
Walters AS (1995) Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 10(5):634–642
Stefanidis I, Vainas A, Giannaki CD, Dardiotis E, Spanoulis A, Sounidaki M, Eleftheriadis T, Liakopoulos V, Karatzaferi C, Sakkas GK, Zintzaras E, Hadjigeorgiou GM (2015) Restless legs syndrome does not affect 3-year mortality in hemodialysis patients. Sleep Med 16(9):1131–1138
Ohayon MM, O’Hara R, Vitiello MV (2012) Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev 16(4):283–295
Ma JF, Xin XY, Liang L, Liu LH, Fang R, Zhang YJ, Wang DY, Fahn S, Tang HD, Chen SD (2012) Restless legs syndrome in Chinese elderly people of an urban suburb in Shanghai: a community-based survey. Parkinsonism Relat Disord 18(3):294–298
Lee J, Nicholl DD, Ahmed SB, Loewen AH, Hemmelgarn BR, Beecroft JM, Turin TC, Hanly PJ (2013) The prevalence of restless legs syndrome across the full spectrum of kidney disease. J Clin Sleep Med 9(5):455–459
Ogna A, Forni Ogna V, Haba Rubio J, Tobback N, Andries D, Preisig M, Tafti M, Vollenweider P, Waeber G, Marques-Vidal P, Heinzer R (2016) Sleep characteristics in early stages of chronic kidney disease in the HypnoLaus cohort. Sleep 39(4):945–953
Lin CH, Wu VC, Li WY, Sy HN, Wu SL, Chang CC, Chiu PF, Lion HH, Lin CY, Chang HW, Lin SY, Wu KD, Chen YM, Wu RM (2013) Restless legs syndrome in end-stage renal disease: a multicenter study in Taiwan. Eur J Neurol 20(7):1025–1031
Stefanidis I, Vainas A, Dardiotis E, Giannaki CD, Gourli P, Papadopoulou D, Vakianis P, Patsidis E, Eleftheriadis T, Liakopoulos V, Pournaras S, Sakkas GK, Zintzaras E, Hadjigeorgiou GM (2013) Restless legs syndrome in hemodialysis patients: an epidemiologic survey in Greece. Sleep Med 14(12):1381–1386
Pizza F, Persici E, La Manna G, Campieri C, Plazzi G, Carretta E, Cappuccilli ML, Ferri B, Stefoni S, Montagna P (2012) Family recurrence and oligo-anuria predict uremic restless legs syndrome. Acta Neurol Scand 125(6):403–409
Sabry AA, Abo-Zenah H, Wafa E, Mahmoud K, El-Dahshan K, Hassan A, Abbas TM, Saleh Ael B, Okasha K (2010) Sleep disorders in hemodialysis patients. Saudi J Kidney Dis Transplant 21(2):300–305
Takaki J, Nishi T, Nangaku M, Shimoyama H, Inada T, Matsuyama N, Kumano H, Kuboki T (2003) Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. Am J Kidney Dis 41(4):833–839
Araujo SM, de Bruin VM, Nepomuceno LA, Maximo ML, Daher Ede F, Correia Ferrer DP, de Bruin PF (2010) Restless legs syndrome in end-stage renal disease: clinical characteristics and associated comorbidities. Sleep Med 11(8):785–790
Benz RL, Pressman MR, Hovick ET, Peterson DD (1999) A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study). Am J Kidney Dis 34(6):1089–1095
Sun ER, Chen CA, Ho G, Earley CJ, Allen RP (1998) Iron and the restless legs syndrome. Sleep 21(4):371–377
Trenkwalder C, Allen R, Hogl B, Paulus W, Winkelmann J (2016) Restless legs syndrome associated with major diseases: a systematic review and new concept. Neurology 86(14):1336–1343
Lopes AA, Bragg J, Young E, Goodkin D, Mapes D, Combe C, Piera L, Held P, Gillespie B, Port FK (2002) Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 62(1):199–207
Acknowledgements
This work was supported by grants from the Natural Science Foundation of Anhui Province (1508085MH148). Refinement and implementation of the study were supported by The Second Affiliated Hospital of Anhui Medical University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors declare no conflict of interest.
Ethical standards
The protocol was approved by the Ethics Committee of Anhui Medical University, and informed consent was obtained from all participants.
Rights and permissions
About this article
Cite this article
Xiao, JP., Zhang, GX., Chen, L. et al. Restless legs syndrome in maintenance hemodialysis patients: an epidemiologic survey in Hefei. Int Urol Nephrol 49, 1267–1272 (2017). https://doi.org/10.1007/s11255-017-1573-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-017-1573-3